LOXITANE C Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Loxitane C, and what generic alternatives are available?
Loxitane C is a drug marketed by Teva Branded Pharm and is included in one NDA.
The generic ingredient in LOXITANE C is loxapine hydrochloride. There are eight drug master file entries for this compound. Additional details are available on the loxapine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOXITANE C?
- What are the global sales for LOXITANE C?
- What is Average Wholesale Price for LOXITANE C?
Summary for LOXITANE C
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 13 |
Clinical Trials: | 1 |
Patent Applications: | 382 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LOXITANE C at DailyMed |
![LOXITANE C drug patent expirations Drug patent expirations by year for LOXITANE C](/p/graph/s/t/LOXITANE_C-patent-expirations.png)
Recent Clinical Trials for LOXITANE C
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mylan Pharmaceuticals | Phase 1 |
US Patents and Regulatory Information for LOXITANE C
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Branded Pharm | LOXITANE C | loxapine hydrochloride | CONCENTRATE;ORAL | 017658-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LOXITANE C
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Teva Branded Pharm | LOXITANE C | loxapine hydrochloride | CONCENTRATE;ORAL | 017658-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Teva Branded Pharm | LOXITANE C | loxapine hydrochloride | CONCENTRATE;ORAL | 017658-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LOXITANE C
See the table below for patents covering LOXITANE C around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Netherlands | 140242 | ⤷ Sign Up | |
Switzerland | 485765 | Verfahren zur Herstellung basisch substituierter Heterocyclen | ⤷ Sign Up |
Switzerland | 481941 | Verfahren zur Herstellung basisch substituierter Heterocyclen | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for LOXITANE C
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1389098 | 300609 | Netherlands | ⤷ Sign Up | PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220 |
1389098 | 2013C/054 | Belgium | ⤷ Sign Up | PRODUCT NAME: LOXAPINE; AUTHORISATION NUMBER AND DATE: EU/1/13/823/001 20130225 |
1389098 | C300609 | Netherlands | ⤷ Sign Up | PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |